Global Beta-Nicotinamide Mononucleotide (NMN) Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032

Market Overview

According to DIResearch"s in-depth investigation and research, the global Beta-Nicotinamide Mononucleotide (NMN) market size will reach 498.44 Million USD in 2025 and is projected to reach 1,117.13 Million USD by 2032, with a CAGR of 12.22% (2025-2032). Notably, the China Beta-Nicotinamide Mononucleotide (NMN) market has changed rapidly in the past few years. By 2025, China"s market size is expected to be Million USD, representing approximately % of the global market share.

Research Summary

Beta-Nicotinamide Mononucleotide (NMN) is a compound involved in the production of a molecule called nicotinamide adenine dinucleotide (NAD+), which plays a crucial role in cellular energy metabolism and various biological processes. NMN is a precursor to NAD+ and is converted into NAD+ through enzymatic reactions in the body. NAD+ is essential for proper functioning of enzymes called sirtuins, which are involved in regulating cellular processes such as DNA repair, gene expression, and energy metabolism. NMN has garnered attention due to its potential anti-aging properties and its ability to support cellular health. It is believed that NMN supplementation may help increase NAD+ levels, thereby promoting cellular energy production and potentially counteracting some age-related decline in various tissues. NMN is being studied for its potential benefits in improving metabolic health, enhancing exercise performance, and mitigating age-related diseases. However, further research is needed to fully understand its effects and optimal usage.

The major global  manufacturers of Beta-Nicotinamide Mononucleotide (NMN) include GeneHarbor, Herbalmax, Genex Formulas, Shinkowa Pharmaceutical, Maac10 Formulas, EffePharm, Bontac, Kingdomway, CELFULL, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of Beta-Nicotinamide Mononucleotide (NMN). Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Beta-Nicotinamide Mononucleotide (NMN) market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.

The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Beta-Nicotinamide Mononucleotide (NMN) market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Beta-Nicotinamide Mononucleotide (NMN) industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.    

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Beta-Nicotinamide Mononucleotide (NMN) Include:

GeneHarbor

Herbalmax

Genex Formulas

Shinkowa Pharmaceutical

Maac10 Formulas

EffePharm

Bontac

Kingdomway

CELFULL

Beta-Nicotinamide Mononucleotide (NMN) Product Segment Include:

Content Greater than or Equal to 98%

Content Less than 98%

Beta-Nicotinamide Mononucleotide (NMN) Product Application Include:

Health Care Products

Cosmetics

Others

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend

Chapter 2: Global Beta-Nicotinamide Mononucleotide (NMN) Capacity and Production Analysis

Chapter 3: Global Beta-Nicotinamide Mononucleotide (NMN) Industry PESTEL Analysis

Chapter 4: Global Beta-Nicotinamide Mononucleotide (NMN) Industry Porter's Five Forces Analysis

Chapter 5: Global Beta-Nicotinamide Mononucleotide (NMN) Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis

Chapter 6: Global Beta-Nicotinamide Mononucleotide (NMN) Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)

Chapter 7: Global Beta-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Forecast by Product Type

Chapter 8: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)

Chapter 9: Industrial Chain Analysis, Beta-Nicotinamide Mononucleotide (NMN) Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis

Chapter 10: Research Findings and Conclusion

Chapter 11: Methodology and Data Sources Show more